Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
328.93
+2.79 (0.86%)
At close: Sep 11, 2026, 4:00 PM EDT
328.18
-0.75 (-0.23%)
Pre-market: Sep 14, 2026, 6:01 AM EDT
Natera Employees
Natera had 6,140 employees as of December 31, 2025. The number of employees increased by 1,706 or 38.48% compared to the previous year.
Employees
6,140
Change (1Y)
1,706
Growth (1Y)
38.48%
Revenue / Employee
$440,892
Profits / Employee
-$31,327
Market Cap
47.41B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,140 | 1,706 | 38.48% |
| Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
| Dec 31, 2023 | 3,293 | 275 | 9.11% |
| Dec 31, 2022 | 3,018 | 348 | 13.03% |
| Dec 31, 2021 | 2,670 | 855 | 47.11% |
| Dec 31, 2020 | 1,815 | 776 | 74.69% |
| Dec 31, 2019 | 1,039 | 64 | 6.56% |
| Dec 31, 2018 | 975 | 82 | 9.18% |
| Dec 31, 2017 | 893 | 41 | 4.81% |
| Dec 31, 2016 | 852 | 136 | 18.99% |
| Dec 31, 2015 | 716 | 42 | 6.23% |
| Dec 31, 2014 | 674 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Danaher | 60,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Illumina | 10,080 |
NTRA News
- 4 days ago - Natera assumed with a Buy at UBS - TheFly
- 6 days ago - Natera initiated with a Buy at Rothschild & Co Redburn - TheFly
- 11 days ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 12 days ago - Natera announces publication of new data in Blood Neoplasia on Signatera - TheFly
- 13 days ago - New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma - Business Wire
- 16 days ago - Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer - Business Wire
- 18 days ago - Natera and Angiex partner in tumor testing using Signatera - TheFly
- 18 days ago - Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™ - Business Wire